Pangenomic Health Inc. announced a private placement of 20,000,000 units at a price of CAD 0.05 per unit for the gross proceeds of CAD 1,000,000 on May 17, 2024. Each Unit will consist of one Class A Common share in the capital of the company and one share purchase warrant with each Warrant being exercisable for one additional common share at a price of CAD 0.10 per warrant share for a period of 24 months from the date of issuance. The securities issued pursuant to the Offering are subject to a four month plus one day hold period under applicable Canadian securities laws.

Pursuant to the policies of the Canadian Securities Exchange, the Offering is expected to close five business days from the date of this announcement.